
ABSLLIQUID
NSEPrice History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Trend
Price above all key MAs — strong uptrend
Price Action
Support & Resistance Levels
Volume Analysis
Recent MA Crossovers
Stop Loss Levels
Fixed Risk
Technical Levels
Financials
Peer Comparison
Mutual Fund SchemePeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SETFNIF50 | SBI-ETF Nifty 50 | ₹253.05 | +1.90% |
| NIFTYBETA | UTI Nifty 50 ETF | ₹260.79 | +1.88% |
| GOLDBEES | NIPPON INDIA ETF GOLD BEES | ₹121.92 | +2.21% |
| NIFTYBEES | Nippon India ETF Nifty 50 BeES | ₹267.86 | +1.99% |
| SENSEXBETA | UTI BSE Sensex ETF | ₹832.20 | +2.13% |
| NIFTYIETF | ICICI Prudential Nifty 50 ETF | ₹266.47 | +1.96% |
| SILVERBEES | Nippon India Mutual Fund - Nippon India Silver ETF | ₹229.76 | +3.79% |
| CPSEETF | CPSE ETF | ₹96.82 | -0.24% |
| SENSEXIETF | ICICI Prudential BSE Sensex ETF | ₹863.16 | +2.15% |
| HDFCGOLD | HDFC Mutual Fund-HDFC Gold Exchange Traded Fund | ₹125.86 | +2.13% |
Corporate Information
Latest News
News for ABSLLIQUID
View AllVodafone Idea shares jump 4%; KM Birla says telco navigated through one of its toughest challenges in history
Vodafone Idea shares climbed after shareholders approved a Rs 4,730 crore investment from the Aditya Birla Group, signalling renewed promoter confidence. With funding support, easing AGR pressure and improved ratings, investor focus now shifts to execution, network expansion and the company’s long-term turnaround prospects.
AB Group reaffirms bet on Voda Idea with ₹4,730 Cr infusion
Vodafone Idea shareholders approved a ₹4,730-crore investment from the Aditya Birla Group via preferential allotment of warrants, increasing AB Group's stake to around 13%. Chairman Kumar Mangalam Birla stated the company's focus now shifts to execution across operations, customer service, and network expansion. This capital infusion will support capital expenditure and loan repayment, reinforcing Vi's financial health.
Market Trading Guide: Akums Drugs among 4 stock recommendations for Thursday
Domestic equities ended lower amid global uncertainty and caution ahead of key US inflation data. Despite market weakness, analysts remain bullish on Akums Drugs and Aditya Birla Sun Life AMC after strong technical breakouts, rising volumes and improving momentum indicators.